More: Janssen Receives Positive CHMP Opinions for Novel Bispecific Antibodies TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) for the Treatment of...
More: Janssen Receives Positive CHMP Opinions for Novel Bispecific Antibodies TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) for the Treatment of...
Read the original post: CHMP recommends Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
See the rest here: Pharvaris Presents Clinical Data at the 2023 U.S. HAEA National Summit
View original post here: Mydecine Innovations Group Provides Corporate Update
Go here to see the original: ARCA biopharma Announces Second Quarter 2023 Financial Results
Continue reading here: Verrica Pharmaceuticals Announces FDA Approval of YCANTH™ (cantharidin) topical solution as the First FDA approved Treatment of Pediatric and Adult...
View original post here: Agra Ventures Announces Results of its Annual General & Special Meeting
Here is the original post: Bavarian Nordic Provides Update on RSV Vaccine Program
Read the rest here: T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
See the rest here: Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023
Recent Comments